Literature DB >> 29625313

An Unusual Case of Lhermitte-Duclos Disease Manifesting with Intratumoral Hemorrhage.

Daiki Uchida1, Hirokazu Nakatogawa2, Chikanori Inenaga2, Tokutaro Tanaka2.   

Abstract

BACKGROUND: Lhermitte-Duclos disease (LDD) is a rare neurologic disease that causes a hamartomatous lesion in the cerebellum. LDD is usually associated with mass lesion effects, but with appropriate surgical treatment, the clinical course is usually benign. We report a rare case of a patient with LDD with contrast enhancement on magnetic resonance imaging (MRI) who died as a result of intratumoral hemorrhage. CASE DESCRIPTION: LDD was diagnosed in a 59-year-old woman after a routine MRI. She did not present with any symptoms initially or after follow-up MRI suggested minor hemorrhage in the tumor. Eleven months after her first visit to our department, she suddenly lost consciousness, and computed tomography revealed massive intratumoral hemorrhage. Surgical decompression was done, but she died 17 days after surgery. Histopathologic findings were consistent with LDD.
CONCLUSIONS: Hemorrhagic events can occur with LDD, even though the growth of the lesion is slow. Long-term close follow-up of patients with LDD is needed, especially patients in whom MRI shows atypical enhancement. To avoid possible hemorrhagic events, surgical treatment should be considered even if only subtle changes are seen on neuroimaging.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Contrast enhancement; Dysplastic gangliocytoma; Hemorrhage; Lhermitte-Duclos disease; Magnetic resonance imaging

Mesh:

Year:  2018        PMID: 29625313     DOI: 10.1016/j.wneu.2018.03.184

Source DB:  PubMed          Journal:  World Neurosurg        ISSN: 1878-8750            Impact factor:   2.104


  1 in total

1.  Dysplastic gangliocytoma of the cerebellum (Lhermitte-Duclos disease) presenting as a prenatally heterotopic hamartoma.

Authors:  Chloé Puiseux; Maxime Bretonnier; Maia Proisy; Céline Chappé; Philippe Denizeau; Laurent Riffaud
Journal:  Childs Nerv Syst       Date:  2020-07-03       Impact factor: 1.475

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.